Evidence map›Paper›PMID 35645822›Full record

ReviewFrontiers in pharmacology2022

Mechanism of Cordyceps sinensis and its Extracts in the Treatment of Diabetic Kidney Disease: A Review.

Wu Liu, Yiwei Gao, Yi Zhou, Fangning Yu, Xinyi Li, Ning Zhang

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. FermentedRenal failure · 2024
    Pooled it
  2. Frontiers in pharmacology · 2024
    Pooled it
  3. Efficacy of traditional Chinese medicineFrontiers in medicine · 2024
    Pooled it
  4. Efficacy and safety ofFrontiers in pharmacology · 2023
    Pooled it
  5. The efficacy ofRenal failure · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. A Progressive Feature Learning Network forSensors (Basel, Switzerland) · 2025
    Article
  10. Review
  11. Article
  12. Impact ofFrontiers in pharmacology · 2025
    Article
  13. Article
  14. Evaluation of Lipid Changes During the Drying Process ofJournal of fungi (Basel, Switzerland) · 2024
    Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wu LiuWangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Yiwei GaoWangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Yi ZhouDepartment of Graduate Student, Beijing University of Chinese Medicine, Beijing, China.
Fangning YuDepartment of Graduate Student, Beijing University of Chinese Medicine, Beijing, China.
Xinyi LiWangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Ning ZhangWangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic kidney disease (DKD) is the major reason of chronic kidney disease (CKD)-caused end-stage renal failure (ESRF), and leads to high mortality worldwide. At present, the treatment of DKD is mainly focused on controlling the hyperglycemia, proteinuria, and hypertension, but is insufficient on the effective delay of DKD progression.

Indexed as

Cordyceps sinensisdiabetic kidney diseasehyperglycemiainflammationoxidative stress

Identifiers

PMID35645822
PMCPMC9136174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.